Research Reports

Q4 2025 total revenue $20.1M, up 16% sequentially and 30% YoY, above guidance top end (CFO)
Full-year 2025 total revenue $70.6M, up 22% YoY (CFO)
Q4 2025 variable royalties set a new record, up 50% YoY; number of large royalty reporters tripled in last 2 years (CFO)
Annual contract value (ACV) plus royalties at Q4 end: $83.6M, up 28% YoY, a record high (CEO, CFO)
Remaining performance obligations (RPO) at Q4 end: $117M, up 32% YoY, a record high; ~half expected to be recognized as revenue in 2026 (CFO)
Non-GAAP gross margin Q4: 92%; full-year 2025: 92% (CFO)
Non-GAAP operating loss Q4: $2.2M; full-year 2025: $12.5M, a $2.4M improvement YoY (CFO)
Free cash flow: positive $3M in Q4, positive $5.3M for full-year 2025 (CFO)
Cash, cash equivalents and investments at year-end: $59.5M; no financial debt (CFO)
Customers have shipped over 4 billion chips and chiplets incorporating Arteris network-on-chip IP (CEO)
Cycuity acquisition closed January 14, 2026; not included in 2025 results (CFO)

Official Guidance (2026)

Q1 2026: ACV plus royalties $85M–$89M; revenue $20.5M–$21.5M; non-GAAP operating loss $3.5M–$2.5M; non-GAAP free cash flow negative $1.5M–positive $1.5M (CFO)
Full-year 2026: ACV plus royalties to exit at $100M–$104M; revenue $89M–$93M (including ~~$7M from Cycuity); non-GAAP operating loss $9M–$5M (~~$1M related to Cycuity); non-GAAP free cash flow positive $5M–$9M (CFO)
Company expects to report a non-GAAP operating profit as early as Q4 2026 (CFO)

Mgmt Quotes

"In the fourth quarter of 2025, we achieved many company records and milestones, including yet another record annual contract value plus royalties of $83.6 million, which represents a 28% year-on-year increase." (CEO)
"Our customers have now shipped over 4 billion chips and chiplets, incorporating Arteris network-on-chip IP as the underlying interconnect." (CEO)
"The Cycuity acquisition will help us to address market concerns about the rapidly increasing volume of sophisticated cyber attacks targeting the vast amounts of data moving to semiconductors." (CEO)
"We had a strong fourth quarter, beating our guidance on all financial measures." (CFO)
"Building on the strong deal execution in 2025... we continue to believe that Arteris is on a path to profitability, as we expect to report a non-GAAP operating profit for a period as early as the fourth quarter of 2026." (CFO)

Metric	Value	Speaker/Context
Total Revenue (Q4 2025)	$20.1M	CFO
Total Revenue (FY 2025)	$70.6M	CFO
ACV + Royalties (Q4 end)	$83.6M	CEO, CFO
RPO (Q4 end)	$117M	CFO
Non-GAAP Gross Margin (Q4)	92%	CFO
Non-GAAP Gross Margin (FY)	92%	CFO
Non-GAAP Operating Loss (Q4)	$2.2M	CFO
Non-GAAP Operating Loss (FY)	$12.5M	CFO
Free Cash Flow (Q4)	Positive $3M	CFO
Free Cash Flow (FY)	Positive $5.3M	CFO
Cash & Investments (year-end)	$59.5M	CFO
Variable Royalties YoY Growth (FY)	50%	CFO
RPO YoY Growth	32%	CFO
ACV + Royalties YoY Growth	28%	CEO, CFO
Revenue YoY Growth (FY)	22%	CFO
Revenue YoY Growth (Q4)	30%	CFO
Non-GAAP Operating Loss Guidance (Q1 2026)	$3.5M–$2.5M	CFO
Revenue Guidance (Q1 2026)	$20.5M–$21.5M	CFO
Revenue Guidance (FY 2026)	$89M–$93M	CFO
ACV + Royalties Exit Guidance (FY 2026)	$100M–$104M	CFO
Non-GAAP Free Cash Flow Guidance (FY 2026)	Positive $5M–$9M	CFO